Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Complete title: Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma

Research Study Number NRG-BN003
Principal Investigator Lia Halasz
Phase III

Research Study Description

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number NRG-BN003
Contact Seattle Cancer Care Alliance Intake Office
Telephone 800-804-8824 / 206-606-1024

Keywords: Central Nervous System (CNS); Solid Tumors; Meningioma; Neoplasms; Neoplasms, Nerve Tissue; Nervous System Diseases; Neoplasms, Vascular Tissue; Meningeal Neoplasms

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials